Evidence map›Paper›PMID 32548302›Full record

ArticleTomography (Ann Arbor, Mich.)2020

4D-CT Attenuation Correction in Respiratory-Gated PET for Hypoxia Imaging: Is It Really Beneficial?

Brandon Driscoll, Douglass Vines, Tina Shek, Julia Publicover, Ivan Yeung, Stephen Breen, David Jaffray

Open access · goldAbstract read
In one paragraph

Article in Tomography (Ann Arbor, Mich.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Brandon DriscollQuantitative Imaging for Personalized Cancer Medicine Program-Techna Institute, University Health Network, Toronto, ON, Canada.
Douglass VinesRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada; and.
Tina ShekQuantitative Imaging for Personalized Cancer Medicine Program-Techna Institute, University Health Network, Toronto, ON, Canada.
Julia PublicoverQuantitative Imaging for Personalized Cancer Medicine Program-Techna Institute, University Health Network, Toronto, ON, Canada.
Ivan YeungQuantitative Imaging for Personalized Cancer Medicine Program-Techna Institute, University Health Network, Toronto, ON, Canada.
Stephen BreenRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada; and.
David JaffrayQuantitative Imaging for Personalized Cancer Medicine Program-Techna Institute, University Health Network, Toronto, ON, Canada.
University Health Network · CAUniversity of Toronto · CAPrincess Margaret Cancer Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous literature has shown that 4D respiratory-gated positron emission tomography (PET) is beneficial for quantitative analysis and defining targets for boosting therapy. However the case for addition of a phase-matched 4D-computed tomography (CT) for attenuation correction (AC) is less clear. We seek to validate the use of 4D-CT for AC and investigate the impact of motion correction for low signal-to-background PET imaging of hypoxia using radiotracers such as FAZA and FMISO. A new insert for the Modus Medicals' QUASAR™ Programmable Respiratory Motion Phantom was developed in which a 3D-printed sphere was placed within the "lung" compartment while an additional compartment is added to simulate muscle/blood compartment required for hypoxia quantification. Experiments are performed at 4:1 or 2:1 signal-to-background ratio consistent with clinical FAZA and FMISO imaging. Motion blur was significant in terms of SUV

Indexed as

Four-Dimensional Computed TomographyHypoxiaLung DiseasesHumansPhantoms, ImagingPositron-Emission Tomography4D-PEThypoxiaphantomquality assurancerespiratory gating

Identifiers

PMID32548302
PMCPMC7289254
OpenAlexW3033635662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.